Read Time:9 Second
While Abbott Laboratories beat analysts’ expectations due to demand for Covid-19 at-home tests, a decline by its medical-device business and broader headwinds helped send its shares down.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0